U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Mitochondrial DNA Deletion Syndromes

MedGen UID:
433158
Concept ID:
CN043632
Disease or Syndrome
Related genes: MGME1, TWNK, RRM2B, FBXL4, SUCLA2, SUCLG1, TFAM, MPV17, DGUOK

Disease characteristics

Excerpted from the GeneReview: Mitochondrial DNA Deletion Syndromes
Mitochondrial DNA (mtDNA) deletion syndromes predominantly comprise three overlapping phenotypes that are usually simplex (i.e., a single occurrence in a family), but rarely may be observed in different members of the same family or may evolve from one clinical syndrome to another in a given individual over time. The three classic phenotypes caused by mtDNA deletions are Kearns-Sayre syndrome (KSS), Pearson syndrome, and progressive external ophthalmoplegia (PEO). KSS is a progressive multisystem disorder defined by onset before age 20 years, pigmentary retinopathy, and PEO; additional features include cerebellar ataxia, impaired intellect (intellectual disability, dementia, or both), sensorineural hearing loss, ptosis, oropharyngeal and esophageal dysfunction, exercise intolerance, muscle weakness, cardiac conduction block, and endocrinopathy. Pearson syndrome is characterized by sideroblastic anemia and exocrine pancreas dysfunction and may be fatal in infancy without appropriate hematologic management. PEO is characterized by ptosis, impaired eye movements due to paralysis of the extraocular muscles (ophthalmoplegia), oropharyngeal weakness, and variably severe proximal limb weakness with exercise intolerance. Rarely, a mtDNA deletion can manifest as Leigh syndrome. [from GeneReviews]
Authors:
Amy Goldstein  |  Marni J Falk   view full author information

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  

Professional guidelines

PubMed

Genovese A, Butler MG
Int J Mol Sci 2020 Jul 2;21(13) doi: 10.3390/ijms21134726. PMID: 32630718Free PMC Article
McCormick E, Place E, Falk MJ
Neurotherapeutics 2013 Apr;10(2):251-61. doi: 10.1007/s13311-012-0174-1. PMID: 23269497Free PMC Article
Ruitenbeek W, Wendel U, Hamel BC, Trijbels JM
J Inherit Metab Dis 1996;19(4):581-7. doi: 10.1007/BF01799118. PMID: 8884581

Recent clinical studies

Etiology

Almarzooqi F, Vallance H, Mezei M, Lehman A, Horvath G, Rakic B, Zypchen L, Mattman A
Acta Haematol 2023;146(3):220-225. Epub 2023 Feb 10 doi: 10.1159/000529311. PMID: 36774923
Sadikovic B, Wang J, El-Hattab AW, Landsverk M, Douglas G, Brundage EK, Craigen WJ, Schmitt ES, Wong LJ
PLoS One 2010 Dec 20;5(12):e15687. doi: 10.1371/journal.pone.0015687. PMID: 21187929Free PMC Article

Diagnosis

Almarzooqi F, Vallance H, Mezei M, Lehman A, Horvath G, Rakic B, Zypchen L, Mattman A
Acta Haematol 2023;146(3):220-225. Epub 2023 Feb 10 doi: 10.1159/000529311. PMID: 36774923
Reynolds E, Byrne M, Ganetzky R, Parikh S
Mol Genet Metab 2021 Dec;134(4):301-308. Epub 2021 Nov 14 doi: 10.1016/j.ymgme.2021.11.004. PMID: 34862134

Prognosis

Reynolds E, Byrne M, Ganetzky R, Parikh S
Mol Genet Metab 2021 Dec;134(4):301-308. Epub 2021 Nov 14 doi: 10.1016/j.ymgme.2021.11.004. PMID: 34862134
Wild KT, Goldstein AC, Muraresku C, Ganetzky RD
Am J Med Genet A 2020 Feb;182(2):365-373. Epub 2019 Dec 11 doi: 10.1002/ajmg.a.61433. PMID: 31825167Free PMC Article

Clinical prediction guides

Reynolds E, Byrne M, Ganetzky R, Parikh S
Mol Genet Metab 2021 Dec;134(4):301-308. Epub 2021 Nov 14 doi: 10.1016/j.ymgme.2021.11.004. PMID: 34862134

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...